Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer

Annals of Surgical Oncology

Volumn 14, Issue 2, 2007, Pages 954-959

  Prenzel, Klaus L ^a   König, Alexandra ^b   Schneider, Paul M ^a   Schnickmann, Christian ^a   Baldus, Stephan E ^c   Schröder, Wolfgang ^a   Bollschweiler, Elfriede ^a   Dienes, Hans P ^a   Mueller, Rolf P ^a   Izbicki, Jakob R ^b   Hölscher, Arnulf H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Esophageal cancer; Neoadjuvant therapy; Nodal micrometastasis

Indexed keywords

ANTIBODY; CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER REGRESSION; CONTINUOUS INFUSION; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; MULTIMODALITY CANCER THERAPY; TREATMENT RESPONSE; TUMOR CELL;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT;

EID: 33846592293     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9141-6     Document Type: Article

References (28)

1. Refaely Y, Krasna MJ. Multimodality therapy for esophageal cancer. Surg Clin North Am 2002; 82(4):729-46.
2. Izbicki JR, Hosch SB, Pichlmeier U, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997; 337(17):1188-94.
3. Hosch SB, Stoecklein NH, Pichlmeier U, et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 2001; 19(7):1970-5.
4. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19(2):305-13.
5. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335(7):462-7.
6. Group MRCOCW. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359(9319):1727-33.
7. Schneider PM, Baldus SE, Metzger R, et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg 2005; 242(5):684-92.
8. Scheunemann P, Izbicki JR, Pantel K. Tumorigenic potential of apparently tumor-free lymph nodes. N Engl J Med 1999; 340(21):1687.
9. Bollschweiler E, Schroder W, Holscher AH, Siewert JR. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 2000; 87(8):1106-10.
10. Sobin LH, Wittekind C. (1997) International Union Against Cancer (UICC) TNM Classification Of Malignant Tumors5 Wiley, New York, .
11. Holscher AH, Schroder W, Bollschweiler E, et al. How safe is high intrathoracic esophagogastrostomy?. Chirurg 2003; 74(8):726-733.
12. Schroder W, Monig SP, Baldus SE, et al. Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann Surg Oncol 2002; 9(8):807-11.
13. Japanese Gastric Cancer A. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998; 1(1):10-24.
14. Baldus SE, Monig SP, Schroder W, et al. Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation. Pathologe 2004; 25(6):421-427.
15. Darnton SJ, Allen SM, Edwards CW, Matthews HR. Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy. J Clin Pathol 1993; 46(1):51-5.
16. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47(1):207-14.
17. Baldus SE, Zirbes TK, Engel S, et al. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer 1998; 79(2):133-8.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:187-220.
19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50(3):163-70.
20. Jiao X, Krasna MJ. Clinical significance of micrometastasis in Lung and esophagela cancer: a new paradigm in thoracic oncology. Ann Thorac Surg 2002; 74:278-284.
21. Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 91(11):2165-74.
22. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185(6):538-43.
23. Kaklamanos IG, Walker GR, Ferry K, et al. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003; 10(7):754-61.
24. Natsugoe S, Matsumoto M, Nakshima S, et al. Effect of neoadjuvant chemotherapy for lymph node micrometastasis and tumor cell microinvolvement in patients with esophageal carcinoma. Cancer Letters 2000; 159:119-125.
25. Pantel K, Schlimok G, Braun S. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. N Engl J Med 1993; 85:1419-1424.
26. Braun S, Kentenich C, Janni W, et al. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 2000; 18:80-86.
27. Kienle P, Koch M, Autschbach F, et al. Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation: a first step towards a molecular surrogate marker for neoadjuvant treatment in colorectal cancer. Ann Surg 2003; 238(3):324-331.
28. Koshy M, Esiashvilli N, Landry JC, et al. Multiple managemet modalities in esophageal cancer: combined modality management approaches. The Oncologist 2004; 9:147-159.